Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure.

scientific article published in August 2003

Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5414/CNP60090
P698PubMed publication ID12940610

P2093author name stringK Miyagawa
T Inoue
T Nakanishi
M Izumi
N Shibahara
Y Takamitsu
R Itahana
P433issue2
P407language of work or nameEnglishQ1860
P921main subjecttype 2 diabetesQ3025883
pharmacokineticsQ323936
P304page(s)90-95
P577publication date2003-08-01
P1433published inClinical NephrologyQ15763520
P1476titlePharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure
P478volume60

Reverse relations

cites work (P2860)
Q36101262Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis
Q26768488Diabetes mellitus and renal failure: Prevention and management
Q59220162Diabetic nephropathy
Q26799515Hypoglycemia in Patients with Diabetes and Renal Disease
Q26766259Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control
Q33792375Management of diabetes mellitus in patients with chronic kidney disease
Q42157131Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure
Q38063169Management of post-transplant diabetes
Q47145533Meglitinides increase the risk of hypoglycemia in diabetic patients with advanced chronic kidney disease: a nationwide, population-based study
Q38193694Metformin and other antidiabetic agents in renal failure patients
Q92431835POTENTIAL ADVANTAGE OF REPAGLINIDE MONOTHERAPY IN GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND SEVERE RENAL IMPAIRMENT
Q28073342Update on the treatment of type 2 diabetes mellitus

Search more.